D a y L o g | |||||||||
Monday | 29. novembra 2004 | ||||||||
Act. No. | Activity | nb | Began | Ended | Length | prescribed | Bonus / Deficit | ||
ideal | less | least | |||||||
I | SL | -1.25 | 5 | 6.25 | 7 | 6 | 5.5 | 0.75 | |
II | EX | 10.5 | 12 | 1.5 | 0.75 | -0.75 | |||
III | MCh | 47 | 5 | 12.5 | 1.75 | 1.25 | -0.5 | ||
II–III | M | 3.25 | 2 | -1.25 | |||||
IV | FL | 0.25 | ms | ||||||
V | PrM | 0.25 | ms | ||||||
VI | QU | 0.5 | ms | ||||||
IV–VI | US | 1 | ms | ||||||
VII | S1 | 4 | 2.75 | 2 | ms | ||||
VIII | S2a | 1 | |||||||
IX | FP | 48 | 8 | 23.25 | 4.5 | 2.5 | 4 | -0.5 | |
X | FA | 6.75 | 8 | 1.25 | 2.5 | 4 | -1.25 | ||
XI | F | 12.5 | 13.5 | 1 | 2.5 | 4 | -1 | ||
XII | NCh | 49 | 13.5 | 18.5 | 5 | 2 | -3 | ||
XIII | PrN | 0.25 | ms | ||||||
XIV | NP | 0.75 | ms | ||||||
XII–XIV | N | 5 | 3 | NA | |||||
XV | S2b | 3 | 2.75 | 2 | ms | ||||
XVI | S3 | 1.5 | 3 | ||||||
VII | S1 | 4 | 2.75 | 2 | -2 | ||||
VIII + XV | S2 | 4 | 2.75 | 2 | -2 | ||||
XVI | S3 | 1.5 | 3 | ||||||
VII+VIII+XV | PS | 8 | 5.5 | 4 | -4 | ||||
VII+VIII+XV+XVI | RS | 8 | 5.5 | 4 | -4 | ||||
IX–XI | FS | 6.75 | 2.5 | 4 | -2.75 | ||||
S | 5.75 | 9.5 | 7 | 5.5 | -3.75 | ||||
XVIIa | ECh1 | 23.25 | 23.75 | 0.5 | 5 it. | ok | |||
XVIIb | ECh2 | na | ms | ||||||
XVIIc | TXT | na | ok | ||||||
XVIId | PRG | na | ms | ||||||
XVII | ECh | 0.5 | 1.5 | 1 | |||||
XVIIIa | EML1 | 6.25 | 6.75 | 0.5 | na | ok | |||
XVIIIb | EML2 | 19 | 21.75 | 2.75 | na | ||||
XIX | AL | 1.25 | 2.25 | 2.75 | |||||
XVIII–XIX | Out | 3.25 | 1.25 | 2.25 | 2.75 | -2 | |||
XX | JR | 0.25 | ms | ||||||
XXI | PrB | ms | |||||||
I + XIV | SLS | 6.25 | 7.75 | 6.75 | 6.25 | 1.5 | |||
I | SL | 23.75 | 7 | 6 | 5.5 | ||||
6.25 | 12 | MCh | 4 | ok | |||||
10.5 | 18.5 | 19 | 21.75 | ||||||
includes a Wolfean Relapse | -24 | -1 | -1 |